TDOC
Teladoc Health, Inc. NYSE$6.63
Mkt Cap $1.2B
52w Low $4.40
41.5% of range
52w High $9.77
50d MA $5.42
200d MA $6.88
P/E (TTM)
-5.7x
EV/EBITDA
10.1x
P/B
0.8x
Debt/Equity
0.8x
ROE
-14.5%
P/FCF
4.3x
RSI (14)
—
ATR (14)
—
Beta
2.08
50d MA
$5.42
200d MA
$6.88
Avg Volume
5.7M
About
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, i…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | -0.34 | -0.36 | -5.5% | 5.95 | -10.9% | +1.8% | +8.6% | — | — | — | — | — |
| Feb 25, 2026 | AMC | -0.19 | -0.14 | +26.3% | 4.65 | +2.4% | +15.1% | +13.1% | +11.0% | +9.7% | +10.3% | +10.5% | — |
| Oct 29, 2025 | AMC | -0.26 | -0.21 | +19.2% | 8.23 | -1.6% | +6.2% | +4.9% | -1.1% | -3.0% | -2.1% | -7.8% | — |
| Jul 29, 2025 | AMC | -0.27 | -0.19 | +29.6% | 7.53 | +1.6% | -1.7% | -4.2% | -7.8% | -7.4% | -7.6% | +4.8% | — |
| Apr 30, 2025 | AMC | -0.33 | -0.19 | +42.4% | 7.19 | +0.8% | -2.8% | -1.8% | -0.6% | -5.7% | -4.6% | -3.8% | — |
| Feb 26, 2025 | AMC | -0.21 | -0.28 | -33.3% | 10.99 | -9.9% | -13.6% | -13.0% | -14.2% | -16.3% | -17.8% | -26.4% | — |
| Oct 30, 2024 | AMC | -0.29 | -0.19 | +34.5% | 8.86 | +5.8% | +1.6% | +4.0% | +0.1% | +3.3% | +6.5% | +35.2% | — |
| Jul 31, 2024 | AMC | -0.36 | -0.28 | +22.2% | 9.43 | -13.8% | -8.9% | -15.7% | -19.4% | -20.6% | -24.1% | -24.0% | — |
| Apr 25, 2024 | AMC | -0.47 | -0.49 | -4.3% | 13.33 | -4.9% | -2.4% | +0.5% | -4.4% | -3.9% | -2.6% | -14.8% | — |
| Feb 20, 2024 | AMC | -0.22 | -0.17 | +22.7% | 20.49 | -18.3% | -23.7% | -25.8% | -29.2% | -27.8% | -26.0% | -25.4% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8 | Evercore ISI | Maintains | In Line → In Line | — | $5.32 | $5.60 | +5.3% | -0.9% | -1.3% | -4.1% | -1.9% | -1.5% |
| Mar 26 | Barclays | Maintains | Equal Weight → Equal Weight | — | $5.57 | $5.47 | -1.8% | -0.9% | -7.7% | -7.7% | -2.2% | -5.2% |
| Mar 13 | JP Morgan | Maintains | Neutral → Neutral | — | $5.36 | $5.44 | +1.5% | +0.2% | +0.6% | +4.7% | +1.1% | +3.0% |
| Mar 10 | Deutsche Bank | Upgrade | Hold → Buy | — | $5.30 | $6.01 | +13.4% | +5.1% | +3.2% | +1.1% | +1.3% | +1.7% |
| Mar 3 | Oppenheimer | Maintains | Outperform → Outperform | — | $5.16 | $4.99 | -3.3% | -1.2% | -0.6% | -0.8% | -1.6% | +2.7% |
| Mar 3 | Citigroup | Maintains | Neutral → Neutral | — | $5.16 | $4.99 | -3.3% | -1.2% | -0.6% | -0.8% | -1.6% | +2.7% |
| Feb 26 | BMO Capital | Maintains | Market Perform → Market Perform | — | $4.65 | $4.76 | +2.4% | +15.1% | +13.1% | +11.0% | +9.7% | +10.3% |
| Feb 26 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $4.65 | $4.76 | +2.4% | +15.1% | +13.1% | +11.0% | +9.7% | +10.3% |
| Feb 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.65 | $4.76 | +2.4% | +15.1% | +13.1% | +11.0% | +9.7% | +10.3% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.65 | $4.76 | +2.4% | +15.1% | +13.1% | +11.0% | +9.7% | +10.3% |
Recent Filings
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Unable to provide analysis: the 8-K lacks specific details about which company experienced the executive change, the position involved, or replacement circumstances needed to assess stock impact.
Mar 30
8-K
Teladoc Health, Inc. -- 8-K Filing
Teladoc Health reported fourth-quarter and full-year 2025 financial results, showing year-over-year performance changes across key metrics for the virtual care leader.
Feb 25
8-K · 5.02
!!! Very High
Teladoc Health, Inc. -- 8-K 5.02: Executive Change
Teladoc Health appoints Michael S. Smith as director effective February 18, 2026, expanding its board composition and potentially signaling strategic leadership changes ahead.
Feb 18
8-K · 5.02
!!! Very High
Teladoc Health, Inc. -- 8-K 5.02: Executive Change
Teladoc Health director McKinley is retiring from the board for personal reasons, representing a routine leadership transition with no indication of internal conflict.
Feb 12
Data updated apr 27, 2026 4:16am
· Source: massive.com